- Patent Title: Agents useful in treating facioscapulohumeral muscular dystrophy
-
Application No.: US15047258Application Date: 2016-02-18
-
Publication No.: US09988628B2Publication Date: 2018-06-05
- Inventor: Alexandra Belayew , Frederique Coppee , Celine Vanderplanck , Stephen Donald Wilton , Eugenie Ansseau
- Applicant: Universite de Mons
- Applicant Address: BE Mons
- Assignee: UNIVERSITE DE MONS
- Current Assignee: UNIVERSITE DE MONS
- Current Assignee Address: BE Mons
- Agency: Knobbe Martens Olson & Bear LLP
- Priority: EP10175125 20100902
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113
Abstract:
The invention teaches antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Further elaborated are methods, uses and further products employing such agents.
Public/Granted literature
- US20170029814A1 AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY Public/Granted day:2017-02-02
Information query
IPC分类:
